PROLONGED REMISSION AFTER TREATMENT WITH SINGLE-AGENT IBRUTINIB AS MAINTENANCE THERAPY FOLLOWING SALVAGE RADIATION THERAPY FOR REFRACTORY/RELAPSE PRIMARY CNS LYMPHOMA

被引：0
|
作者：
Du, Steven [1 ]
Bota, Daniela [2 ]
Kong, Xiao-Tang [3 ]
机构：
[1] Univ Calif Irvine, Irvine, CA USA
[2] Univ Calif Irvine, Dept Neurol, Irvine, CA USA
[3] UC Irvine Hlth, Irvine, CA USA
来源：
NEURO-ONCOLOGY | 2022年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
INNV-18
引用
收藏
页码：145 / 145
页数：1
相关论文
共 50 条
  • [1] Successful Consolidation/Maintenance Therapy with Single Agent Ibrutinib for Primary CNS Lymphoma after Initial Induction Therapy
    Du, Steven
    Bota, Daniela
    Kong, Xiao-Tang
    NEUROLOGY INTERNATIONAL, 2022, 14 (03): : 574 - 580
  • [2] Updated results of single-agent ibrutinib in recurrent/refractory primary (PCNSL) and secondary CNS lymphoma (SCNSL).
    Grommes, Christian
    Gavrilovic, Igor T.
    Kaley, Thomas Joseph
    Nolan, Craig
    Omuro, Antonio Marcilio Padula
    Wolfe, Julia
    Pentsova, Elena
    Hatzoglou, Vaios
    Mellinghoff, Ingo K.
    DeAngelis, Lisa Marie
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [3] Cranial Radiation Therapy as Salvage in the Treatment of Relapsed Primary CNS Lymphoma
    Volpini, Matthew E.
    Song, Jiheon
    Samant, Rajiv
    MacDonald, David
    Nair, Vimoj J.
    CURRENT ONCOLOGY, 2022, 29 (11) : 8160 - 8170
  • [4] Temozolomide as a Single Agent Maintenance Therapy in Elderly Patients With Primary CNS Lymphoma
    Faivre, Geraldine
    Butler, Matthew James
    Le, Isabelle
    Brenner, Andrew
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : 665 - 669
  • [5] PRIMARY DURAL LYMPHOMA: COMPLETE REMISSION AFTER TREATMENT WITH RADIATION THERAPY
    Jones, Jeremy C.
    Gupta, Arjun
    Naina, Harris
    SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES, 2015, 32 (01) : 80 - 82
  • [6] Phase I Study of Single Agent Ibrutinib in Recurrent/Refractory Primary and Secondary CNS Lymphoma
    Christian, Grommes
    Thomas, Kaley
    Abdel-Wahab, Omar
    Omuro, Antonio M.
    Ingo, Mellinghoff
    DeAngelis, Lisa
    BLOOD, 2015, 126 (23)
  • [7] POTENTIAL EFFECTIVE CONSOLIDATION THERAPY WITH SINGLE AGENT IBRUTINIB FOR A CASE WITH PRIMARY CNS LYMPHOMA AFTER INITIAL HD-MTX AND RITUXIMAB INDUCTION THERAPY
    Du, Steven
    Ko, Uvin
    Bota, Daniela
    Kong, Xiao-Tang
    NEURO-ONCOLOGY, 2021, 23 : 111 - 111
  • [8] Efficacy and Safety of Single-Agent Ibrutinib in Patients with Mantle Cell Lymphoma Who Progressed after Bortezomib Therapy
    Wang, Michael
    Goy, Andre
    Martin, Peter
    Ramchandren, Rod
    Alexeeva, Julia
    Popat, Rakesh
    Avivi, Irit
    Advani, Ranjana
    Le Gouill, Steven
    Horowitz, Netanel
    Yuan, Zhilong
    Kranenburg, Britte
    Rizo, Aleksandra
    Zhuang, Sen Hong
    Deraedt, William
    Rule, Simon
    BLOOD, 2014, 124 (21)
  • [9] Single-agent MOR208 salvage and maintenance therapy in a patient with refractory/relapsing diffuse large B-cell lymphoma: A case report
    Jurczak W.
    Bryk A.H.
    Mensah P.
    Gałzka K.
    Trofimiuk-Müldner M.
    Wyrobek Ł.
    Sawiec A.
    Skotnicki A.B.
    Journal of Medical Case Reports, 10 (1)
  • [10] OUTCOMES AFTER STEREOTACTIC RADIATION THERAPY FOR PRIMARY CNS LYMPHOMA
    Shukla, Gaurav
    Palmer, Joshua
    Glass, Jon
    Kim, Lyndon
    Shi, Wenyin
    NEURO-ONCOLOGY, 2016, 18 : 181 - 181
12345